FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Researchers discover new drugs to combat the root cause of MS





















Researchers at the George Washington University and Case Western Reserve University were published this week in Nature for discovery of a potential new treatment focused on brain repair for MS
Read more »

Labels:


 

World Medical Innovation Forum Raises Awareness About MS: VIDEO





















The World Medical Innovation Forum was held over the past three days at the Westin Copley Place in Boston, attracting more than 1,000 attendees and featuring world-renowned experts on brain and nerve disorders. Dr. Mallika Marshall had the honor of moderating a panel on multiple sclerosis Wednesday morning and learned about all of the remarkable advances in treating this disorder that attacks nerves in the brain, the eyes, and the spinal cord and affects more women than men.
Read more »

Labels:


 

Drugs that activate brain stem cells may reverse multiple sclerosis






















Two drugs already on the market — an antifungal and a steroid — may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis. The study was partially funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
Read more »

Labels:


 

Patients, family walk to raise money for Multiple Sclerosis cure: VIDEO




















People were walking for a good cause on Saturday in La Crosse.
Click here to see more

Labels: ,


 

Patient experience with Copaxone (glatiramer acetate) 40 mg/1 mL three-times weekly treatment for relapsing-remitting multiple sclerosis: Results from the GLACIER extension study: STUDY

Wednesday

 

Little-known drug may halt multiple sclerosis, Gladstone study finds
















































Gladstone senior investigator Dr. Eric Verdin: "It is a very complex but significant target."


Blocking a specific protein with a little-known, experimental drug restored balance in the immune systems of lab mice, preventing them from developing multiple sclerosis, researchers at San Francisco's Gladstone Institutes found.
Read more »

 

What happens when multiple sclerosis patients stop taking their medication?



























Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

New research led by NYU Langone Medical Center examines what happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication.
Read more »

 

Former Miss NH advocates for multiple sclerosis research
















































With her pageant and performing days behind her, Michelle Tolson, 41, is now putting herself in the public eye once more — as an advocate in the fight against multiple sclerosis.
Read more »

Labels:


 

Dimethyl fumarate (BG-12) first line oral treatment for people with multiple sclerosis: STUDY

 

Feasibility of Telerehabilitation in Patients with Significant Mobility Disability due to Multiple Sclerosis: STUDY

Tuesday

 

An 80-Proof Solution to Multiple Sclerosis?


























Multiple sclerosis patients who reported consuming hard liquor had significantly less disability according to Expanded Disability Status Score (EDSS) ratings than teetotalers, a researcher reported here.
Read more »

 

A Week Without an MS Fall























It’s been a week today since my last fall!
Read more »

 

Cooling Device May Work for Multiple Sclerosis, but Patients Resisted































Patients with multiple sclerosis (MS) often have sensitivity to heat that worsens their symptoms. In earlier studies with MS patients a device system that cools body temperature by chilling one palm proved useful in helping them walk faster and longer.
Read more »

 

Actelion to accelerate clinical trials for experimental therapy that treats MS, other autoimmune diseases




























Actelion Pharma recently announced that it will accelerate the launch of clinical trials involving its lead drug candidate ponesimod, an oral, selective sphingosine-1-phosphate (S1P1). This decision came after a group of scientists working on different phases of clinical trials for the therapy observed mostly positive effects of ponesimod in terms of efficacy, efficiency and safety in comparison to other therapies.
Read more »

 

Comparison of Relapse Rates in Multiple Sclerosis Patients Switching from Glatiramer Acetate (Copaxone) to Fingolimod (Gilenya) versus Those Remaining on Glatiramer Acetate: STUDY

Monday

 

Stem Cell Transplant Reduces Multiple Sclerosis Disease Activity





































Stem cell transplants are more effective for people with severe cases of multiple sclerosis (MS) than mitoxantrone, according to a study published online in Neurology.
Read more »

Labels:


 

Woman Living With Multiple Sclerosis Still A Healthy Athlete: VIDEO































Joann Dickerson-Smith


More than 2-million people are living with Multiple Sclerosis worldwide, according to the National Multiple Sclerosis Society.
Read more »

Labels: , ,


 

Tommy Hilfiger has been honored for his work with multiple sclerosis































The well known and very wealthy designer Tommy Hilfiger has been investing some of his time towards helping to find a cure for multiple sclerosis. The Economic Times reported on April 26, 2015, Hilfiger has been honored for his work on multiple sclerosis. At the annual Race to Erase MS Gala the creative designer Hilfiger has been honored for his strong commitment to searching for a cure for multiple sclerosis.
Read more »

 

Prescription price shock: OSU/OHSU study takes drug industry to task
















































Lead author Dan Hartung's study found that one drug that originally cost $8,700 now tops $62,000.

Drugs for treating multiple sclerosis have skyrocketed 700 percent in the past 20 years, even as newer drugs have come on the market, according to a study out today from researchers at Oregon State University and Oregon Health & Science University.
Read more »

Labels:


 

Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability: STUDY

Sunday

 

French announce multiple sclerosis breakthrough



























French biotechnology company MedDay has announced encouraging results for a multiple sclerosis (MS) drug trial, saying it decreased its progress and in some cases led to a "significant improvement" for sufferers.
Read more »

Labels: ,


 

Struggling Starlet! Actress Teri Garr’s Frightening Multiple Sclerosis Ordeal — Her Pain Revealed In 12 Photos: SLIDESHOW





















Teri Garr, an Academy Award nominated actress that was once the considered to be the funniest lady in show business, is dealing with a not-so-funny battle with multiple sclerosis and will mostly be confined to a wheel-chair for the rest of her life. Click through these 12 terrifying photos exclusive to RadarOnline.com to see how the brave actress is coping with the awful illness.

Story Source: The above story is based on materials provided by RADARONLINE
Note: Materials may be edited for content and length

Labels:


 

MS at a young age in a small town: Multiple avenues of care


























Luke Merritt packs a bag at his Prosser, Wash. home as he prepares to play in his first baseball game of the season April 14, 2015. Though he has multiple sclerosis, the 12-year-old can still play sports though he gets easily fatigued. Merritt plays on the Prosser Middle School team. (GORDON KING/Yakima Herald-Republic)

About a year ago, when Luke Merritt was 11, he woke up one day with fairly typical allergy symptoms. So his mom gave him an allergy pill. After school, he still felt off, so she gave him another.
Read more »

Labels: ,


 

Multiple Sclerosis Drug Prices Rose at an ‘Alarming’ Rate: STUDY





















There has been an “alarming rise” in the cost of multiple sclerosis treatments over the past dozen years and the cost of these drugs increased at rates well beyond the overall growth in prescription drug prices, according to a new study.
Read more »

Labels:


 

Processing Face Encoding in Multiple Sclerosis: A fMRI Investigation: STUDY

Saturday

 

Scientists identify protein that could help tame severe inflammation





























Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders. St. Jude Children's Research Hospital scientists led the study which appears today in the scientific journal Immunity.
Read more »

 

Important Multiple Sclerosis Research Grants Announced




























The Annette Funicello Research Fund for Neurological Disease (AFRFND) joined with the International Society of Neurovascular Diseases (ISNVD.org) in the Fall of 2014 to request proposals in clinical and basic science research into neurovascular disease emphasizing the relationship to multiple sclerosis (MS) and neurodegeneration.
Read more »

 

TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients











Biogen (NASDAQ: BIIB) today announced new data that continue to support TECFIDERA® (dimethyl fumarate) as an effective, long-term treatment for people who are living with relapsing forms of multiple sclerosis (MS). Data show TECFIDERA significantly reduced relapses and disability progression in newly-diagnosed relapsing-remitting MS (RRMS) patients who had highly active disease. Additional data indicate TECFIDERA showed strong and sustained efficacy over five years in RRMS patients who were previously treated with an interferon (interferon beta-1a/b [IFN]) or glatiramer acetate (GA). These results will be presented at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Read more »

Labels: ,


 

Lake Como walk aims to fund cure for multiple sclerosis



























Team Mustang Sally members Sally Rubino and her husband Mike of Spring Lake Heights, begin the walk. Thousands of walkers participate in Walk MS, presented by BAYADA Home Health Care, in Lake Como. This walk is one of many that took place throughout New Jersey over the weekend to raise money to create a world free of multiple sclerosis. Lake Como, NJ Saturday, April 19, 2015 Doug Hood/Staff Photographer @dhoodhood  (Photo: Staff Photographer, Gannett)

Behrman Park was a sea of orange Sunday morning as walkers gathered for the annual 3.1-mile walk past the lake to the boardwalk and back to Bar Anticipation to raise money for awareness and to fund research projects that will find a cure for Multiple Sclerosis (MS).
Read more »

 

Greater Consumption of Coffee is Associated with Reduced Odds of Multiple Sclerosis: STUDY

Friday

 

Paralyzed patients can cycle again with new $35K bike from U of C: VIDEO
















A new bicycle that will allow paralyzed patients to cycle was unveiled Wednesday at the University of Calgary.
Read more »

Labels: , ,


 

Is my head in or out of the sand?
























Yesterday was a step for me. I had my first ‘therapy’ session. I recently spoke with my neurologist (well, the PA) about some of the feelings I had been having lately and not being sure whether they were related to post-partum depression, MS-depression, or just depression-depression. She suggested I meet with a lady [LCSW] at the Rocky Mountain MS Center who specializes in MS and ‘talk.’ It sounded like a plan to me! I do a lot of talking already for my career and just in life so this would likely work well [hopefully].
Read more »

Labels: ,


 

Living with multiple sclerosis

























Multiple sclerosis (MS) is widely thought to be a disease of immune dysfunction, whereby the immune system becomes activated to attack components of the nerves in the brain, spinal cord, and optic nerve. New information about environmental factors and lifestyle are giving persons with MS and their health care providers new tools with which to manage the disease and live healthier and more productive lives.
Read more »

 

CorTechs Labs, Novartis partner to advance clinical care, assessment of multiple sclerosis worldwide


























CorTechs Labs, the leading medical software innovator providing solutions for quantitative brain volume analysis is pleased to announce a partnership agreement with Novartis Pharma AG, a global pharmaceutical company. The companies will collaborate to develop NeuroQuant's powerful brain volume quantification report targeting the identification, measurement and tracking of brain volume loss in multiple sclerosis patients.
Read more »

 

Durable Efficacy of Alemtuzumab in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis Who Relapsed on a Prior Therapy

Thursday

 

Drug that boosts nerve signals offers hope for multiple sclerosis






















Myelin (green) protects nerve fibres.


An experimental antibody drug aimed at protecting nerves from the ravages of multiple sclerosis offers hope for a new way to combat the neurological disease — if researchers can definitively show that it works.
Read more »

 

Progressive MS Pipeline Slowly Filling With New, Experimental Therapies


























As the most common non-traumatic cause of disability in young people in the industrialized world, multiple sclerosis affects more than 2.5 million people globally. Those who suffer with the disease are categorized into two types of multiple sclerosis patients: those with relapsing-remitting multiple sclerosis (RRMS) make up the majority of patients (~85%) and those with progressive multiple sclerosis can be further subcategorized into primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS). The disease state of approximately 80% of RRMS patients will transition into SPMS.
Read more »

Labels: ,


 

Epilepsy drug could protect eyesight of MS patients






























The findings of the study are due to be presented at the American Academy of Neurology's (AAN) 67th Annual Meeting in Washington, DC, by Dr. Raju Kapoor, of the National Hospital for Neurology and Neurosurgery in London, UK.
Read more »

 

How Fit Are You?
















































It’s not often that we find a study for MS that might yield results that benefit the person with MS, our doctors and a major pharmaceutical company – and all for the small cost of around $100.

Read more »

Labels: ,


 

Testicular Hypofunction and Multiple Sclerosis Risk: A Record-Linkage Study: STUDY

Wednesday

 

Common athlete's foot cream 'could reverse multiple sclerosis'

























A common athlete’s foot cream sold over the counter at most chemists could cure multiple sclerosis, scientists believe.
Read more »

 

FDA approves first generic Copaxone to treat multiple sclerosis


































The U.S. Food and Drug Administration has approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).
Read more »

Labels:


 

Successfully managing fatique in people with MS






















Sarah Thomas and Peter Thomas

Fatigue is one of the most commonly reported and debilitating symptoms of multiple sclerosis (MS) and can significantly reduce an individual's quality of life. Unlike the tiredness that we all experience sometimes, fatigue in those with MS can have a hugely negative impact – it can limit or stop people from doing day-to-day activities and things that really matter to them. It is the main reason why people with MS stop working. Research undertaken at Bournemouth University (BU) has been tackling the challenge of managing fatigue in people with MS, with encouraging results.
Read more »

Labels:


 

PatientsLikeMe/Biogen study evaluated wearable devices to monitor activity of people with MS.

















Cambridge, Massachusetts based PatientsLikeMe has released results of a novel study conducted in conjunction with pharmaceutical maker Biogen that demonstrated how people living with multiple sclerosis (MS) can employ wearable activity tracking devices to monitor, collect, and share their personal mobility data. That information can potentially be relevant for their clinicians, and for other MS patients.
Read more »

Labels: ,


 

How often is CADASIL diagnosed as multiple sclerosis: STUDY

Tuesday

 

New drug could reverse the damage of multiple sclerosis.

























A new drug could reverse the damage of multiple sclerosis, curing balance and vision problems for sufferers, researchers believe.
Read more »

 

Progressive Multiple Sclerosis Responds to Biotin





























High doses of biotin, which is also known as vitamin H, were associated with improvements in disability among patients with progressive multiple sclerosis. The results of this latest study, which follows on the heels of another research endeavor concerning biotin for multiple sclerosis, will be presented at the American Academy of Neurology annual meeting on April 24, 2015.
Read more »

Labels:


 

Seeking Answers for Progressive MS
















































An invitational meeting in Boston early in March drew more than 80 scientists and clinical researchers to address the vexing question of how to speed treatments for progressive MS. The meeting showcased a cross section of potential disease mechanisms, new animal and computer models, and the scientific underpinnings of clinical trials by drugmakers.
Read more »

Labels: ,


 

Chance treatment worth its weight




















Hamish Bockett-Smith has loaded his mortgage to afford the $200,000 treatment for MS which is only available in New Zealand for cancer patients. Photo / Mark Mitchell


Wellington man has to go to Singapore for therapy cancer patients get in New Zealand.
Read more »

Labels: ,


 

Retinal neuronal and axonal loss over time as markers of disease progression and activity in Multiple Sclerosis: A pilot study: STUDY


Go to Newer News Go to Older News